IPAC Pharmaceuticals is an R&D focused company that is creating innovative treatment-opportunities in the ever-growing industry of ophthalmology and eye care.

Our goal is to vastly improve patient care by bringing world-class eye care technology to the healthcare industry. We are developing new ophthalmic drugs to treat diseases where a significant unmet need exists.

Our leadership team is composed of executives and biotech entrepreneurs that set a strong foundation for the company’s vision. We each bring years of extensive experience and have a long history of success in ophthalmology, R&D execution, and startups. We are dedicated to quickly identifying new technologies and transforming them into beneficial treatments that will help many patients worldwide.

Our vision

We want to bring the latest eye care technology to the healthcare industry. With our unique partnerships and connections, we can identify new technologies and transform them in successful ocular products that can help people worldwide.

Our leadership team

IPAC is led by former top executives from the leading eye care companies in the world. With their collective knowledge of global R&D operations, formulation development, and regulatory, they are driving IPAC to success.

Click on each profile to learn more about our team members.

DAMON BURROWS
DAMON BURROWS
CO-FOUNDER & CHIEF EXECUTIVE OFFICER
WILLIAM PEDRANTI
WILLIAM PEDRANTI
CO-FOUNDER & CHIEF ADMINISTRATIVE OFFICER
GEORGE NG
GEORGE NG
CO-FOUNDER & CHIEF BUSINESS OFFICER
OREST OLEJNIK
OREST OLEJNIK
CHIEF SCIENTIFIC OFFICER
STEVE JOHNSON
STEVE JOHNSON
CHIEF OPERATING OFFICER
YOGESH BAHL
YOGESH BAHL
CHIEF FINANCIAL OFFICER

Our business partners

We’re partnering with the best in the pharmaceutical industry to bring patients effective and innovative eye care products

Clinical development team

IPAC has teamed up with Ora Clinical to help facilitate the development of our products.

Ora is a leading global clinical research organization specializing in eye care with over 40 years experience. Ora’s proprietary clinical models and processes have become standard across multiple ophthalmic therapeutic areas.

IPAC partnership with Ora provides opportunities for multiple pre- and early-clinical assets, as well as deep clinical development and regulatory leadership.

Learn more about Ora at OraClincal.com

IPAC is developing next-generation pain treatments to help the millions of people across the globe living with the debilitating effects of ocular pain

DAMON BURROWS

CO-FOUNDER & CHIEF EXECUTIVE OFFICER

The IPAC team is

finding novel technology

See our R&D technologies